Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer. - Isogai A; Terada M; Wanifuchi-Endo Y; Fujita T; Asano T; Mori M; Nozawa K; Matsumoto N; Niwa Y; Tanaka Y; Kato H; Komura M; et al. (Breast cancer (Tokyo, Japan), 2025)